These emerging medications , Semaglutide , represent a significant advancement in treating type 2 diabetes and possibly associated disorders. These drugs are grouped as GLP-1 receptor agonists , https://abelighb071057.azzablog.com/41796851/semaglutide-a-deep-dive-into-metabolic-compounds